SCHEMBL19080047

SCHEMBL19080047

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5cc6oc7c8ccccc8ccc7c6c6ccccc56)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARSA P15289 1/20 0.44
CDC25A P30304 1/20 0.44
CDC25C P30307 1/20 0.44
CYP1A1 P04798 6/20 0.39
CYP1A2 P05177 6/20 0.39
CYP1B1 Q16678 6/20 0.39
PRKDC P78527 3/20 0.39
CYP3A4 P08684 2/20 0.39
TSHR P16473 2/20 0.39
CYP2C19 P33261 2/20 0.39
KMT2A Q03164 1/20 0.38
AHR P35869 1/20 0.37
PSD A5PKW4 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
ALOX15 P16050 1/20 0.37
HTT P42858 1/20 0.37
PDE5A O76074 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080017 0.89 CYP1A1 (0.44) ARSACDC25ACDC25CCYP1A1CYP1A2
SCHEMBL19076447 0.89 ALOX5 (0.44) ARSACDC25ACDC25CPRKDCKMT2A
SCHEMBL20334473 0.89 ARSA (0.43) ARSACDC25ACDC25CCYP1A1CYP1A2
SCHEMBL18810718 0.88 ARSA (0.39) ARSACDC25ACDC25CCYP1A1CYP1A2
SCHEMBL19076442 0.87 TDP1 (0.37) ARSACDC25ACDC25CKMT2AAHR
SCHEMBL19080079 0.87 CYP1A1 (0.46) ARSACDC25ACDC25CCYP1A1CYP1A2
SCHEMBL19081651 0.87 TDP1 (0.40) ARSACDC25ACDC25CCYP1A1CYP1A2
SCHEMBL13789712 0.87 ALDH1A1 (0.43) CYP1A2TSHRCYP2C19KMT2AAHR
SCHEMBL19080063 0.86 CYP1A1 (0.42) ARSACDC25ACDC25CCYP1A1CYP1A2
SCHEMBL22541942 0.85 ARSA (0.42) ARSACDC25ACDC25CCYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ARSA 4452/4885CDC25A 44/4885CDC25C 132/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ARSA 4452/4885CDC25A 44/4885CDC25C 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.